Investors, NPS Pharma Strike $15M Deal In Preos Suit
The lead plaintiff in a drawn-out securities suit against NPS Pharmaceuticals Inc. has asked the federal court in Utah to approve a $15 million settlement between the drugmaker and stockholders, who...To view the full article, register now.
Already a subscriber? Click here to view full article